Jubilant Pharmova Limited (NSE: JUBLPHARMA)

Jubilant Pharmova Revenue

Jubilant Pharmova had revenue of 17.52B INR in the quarter ending September 30, 2024, with 4.28% growth. This brings the company's revenue in the last twelve months to 69.20B, up 6.49% year-over-year. In the fiscal year ending March 31, 2024, Jubilant Pharmova had annual revenue of 67.03B with 6.71% growth.

• Revenue (ttm): 69.20B
• Revenue Growth: +6.49%
• P/S Ratio: n/a
• Revenue / Employee: 12.82M
• Employees: 5,399
• Market Cap: 180.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	67.03B	4.21B	6.71%
Mar 31, 2023	62.82B	1.52B	2.47%
Mar 31, 2022	61.30B	316.29M	0.52%
Mar 31, 2021	60.99B	1.23B	2.05%
Mar 31, 2020	59.76B	-31.35B	-34.41%